Lilly Endowment Inc - May 23, 2024 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
10%+ Owner
Signature
/s/ Peter A. Buck, Vice President for Investments and Grants Administration, on behalf of Lilly Endowment Inc.
Stock symbol
LLY
Transactions as of
May 23, 2024
Transactions value $
-$41,120,963
Form type
4
Date filed
5/24/2024, 04:00 PM
Previous filing
May 23, 2024
Next filing
May 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Sale -$4.88M -6.06K -0.01% $804.35 98.7M May 23, 2024 Direct F1
transaction LLY Common Stock Sale -$3.94M -4.89K 0% $805.59 98.7M May 23, 2024 Direct F2
transaction LLY Common Stock Sale -$2.82M -3.49K 0% $806.68 98.7M May 23, 2024 Direct F3
transaction LLY Common Stock Sale -$3.16M -3.92K 0% $807.48 98.7M May 23, 2024 Direct F4
transaction LLY Common Stock Sale -$2.08M -2.57K 0% $808.66 98.7M May 23, 2024 Direct F5
transaction LLY Common Stock Sale -$5.52M -6.81K -0.01% $809.66 98.7M May 23, 2024 Direct F6
transaction LLY Common Stock Sale -$1.98M -2.45K 0% $810.71 98.7M May 23, 2024 Direct F7
transaction LLY Common Stock Sale -$4.07M -5.02K -0.01% $811.81 98.7M May 23, 2024 Direct F8
transaction LLY Common Stock Sale -$3.77M -4.64K 0% $812.71 98.7M May 23, 2024 Direct F9
transaction LLY Common Stock Sale -$3.55M -4.36K 0% $813.84 98.7M May 23, 2024 Direct F10
transaction LLY Common Stock Sale -$1.56M -1.91K 0% $814.79 98.7M May 23, 2024 Direct F11
transaction LLY Common Stock Sale -$827K -1.01K 0% $816.01 98.7M May 23, 2024 Direct F12
transaction LLY Common Stock Sale -$1.7M -2.08K 0% $816.82 98.7M May 23, 2024 Direct F13
transaction LLY Common Stock Sale -$661K -808 0% $817.86 98.6M May 23, 2024 Direct F14
transaction LLY Common Stock Sale -$558K -681 0% $818.82 98.6M May 23, 2024 Direct F15
transaction LLY Common Stock Sale -$66.5K -81 0% $820.50 98.6M May 23, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $804.00 to $804.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), and (15) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $805.03 to $806.00, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $806.05 to $807.03, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $807.05 to $808.00, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $808.08 to $809.05, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $809.22 to $810.10, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $810.24 to $811.23, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $811.24 to $812.23, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $812.24 to $813.21, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $813.28 to $814.27, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $814.31 to $815.24, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $815.36 to $816.34, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $816.37 to $817.31, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $817.38 to $818.34, inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.43 to $819.17, inclusive.